Papersleukemia4816046

First Report of a Phase II Prospective Study of Combination of Hyper-CVAD with Ponatinib in Frontline Therapy of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

The Lancet. Oncology · 01-11-2015 · 4816046 on PMC →
278 citations FWCI 21.94 Chronic Myeloid Leukemia Treatments Trend
Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 4816046 is in the queue.

In the meantime: Browse leukemia papers → · Ask about this topic → · Explore the graph →